BioGeneration Ventures (BGV) specializes in early-stage biotech and health tech investments. They fund pioneering companies like Tessellate BIO, writing seed checks to nurture groundbreaking ideas. BGV also supports the Fonds InvesteringsRijpe STarters (FIRST) fund, aiding leading scientists in regenerative medicine and cardiovascular research in the Netherlands. They offer their network, expertise, and resources to help these initiatives grow and succeed.
